Features  |   November 2016
Anesthetic-Related Neurotoxicity – Current State of the Art
Author Affiliations
  • Randall P. Flick, M.D., M.P.H., FAAP
    Committee on Pediatric Anesthesia
    Chair
Article Information
Central and Peripheral Nervous Systems / Pediatric Anesthesia / Features
Features   |   November 2016
Anesthetic-Related Neurotoxicity – Current State of the Art
ASA Monitor 11 2016, Vol.80, 16-18.
ASA Monitor 11 2016, Vol.80, 16-18.
The possibility of anesthetic neurotoxicity was first suggested more than 15 years ago with findings of apoptosis in the brains of rodents after ethanol exposure during critical periods of neurodevelopment. A similar neuroapoptotic effect was soon identified in anesthetic agents and linked to long-term functional consequences. Since then, nearly all commonly used N-methyl-D-aspartate (NMDA) antagonists and γ-amino butyric acid (GABA) agonists have been evaluated and were found to result in neurotoxic effects in a variety of animal species, including non-human primates.1  Hundreds of preclinical studies have now been published demonstrating effects with anesthetic doses relevant to humans and using monitoring standards similar to those used for clinical care in children. Despite the presence of this robust body of preclinical data, however, the clinical evidence is much sparser.
First Page Preview
First page PDF preview
First page PDF preview ×
View Large
0 Comments
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Name
Affiliation & Institution
I have a potential conflict of interest
Comment Title
Comment


This feature is available to Subscribers Only
ASA Member Login or Create an Account ×